HIGHLIGHTS
- who: Yash B. Shah and collaborators from the Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, United States of have published the paper: A scoping review protocol to elucidate outcomes following abiraterone versus enzalutamide for prostate cancer, in the Journal: PLOS ONE of January/31,/2022
- what: Prostate cancer is one of the most common oncologic diagnoses in men, and prognosis for advanced disease can be greatly improved.
- future: The research team will identify gaps in the literature and highlight implications for future research. The results will be used to inform . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.